Short Interest in SeaStar Medical Holding Co. (NASDAQ:ICU) Declines By 11.2%

SeaStar Medical Holding Co. (NASDAQ:ICU) saw a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 370,200 shares, a decline of 11.2% from the January 15th total of 416,700 shares. Based on an average daily trading volume, of 460,800 shares, the short-interest ratio is currently 0.8 days. Approximately 5.4% of the shares of the company are short sold.

Institutional Trading of SeaStar Medical

An institutional investor recently raised its position in SeaStar Medical stock. Geode Capital Management LLC lifted its stake in SeaStar Medical Holding Co. (NASDAQ:ICU) by 14.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 45,430 shares of the company’s stock after buying an additional 5,618 shares during the period. Geode Capital Management LLC owned about 1.02% of SeaStar Medical worth $88,000 at the end of the most recent reporting period. 1.69% of the stock is owned by institutional investors and hedge funds.

SeaStar Medical Price Performance

ICU opened at $1.79 on Tuesday. The business has a 50 day moving average of $1.91 and a 200-day moving average of $3.44. SeaStar Medical has a 1-year low of $1.50 and a 1-year high of $42.92.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.